New strategy aims to keep prostate cancer in check longer
NCT ID NCT06734130
Summary
This study is testing whether adjusting the timing of hormone therapy combined with chemotherapy can help men with advanced prostate cancer stay responsive to standard treatments longer. The trial involves 25 men whose cancer has spread but still responds to hormone-blocking drugs. Researchers want to see if this adaptive approach can delay the cancer's progression and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION SENSITIVE PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Moffitt Caner Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.